Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Claeys

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of the Neurological Sciences|July 1, 1983
Interferon production and natural killer (NK) activity in leukocyte cultures from multiple sclerosis patientsG Vervliet, H Claeys, H Van Haver, et al.
Acta Stomatologica Belgica|June 1, 1992
[Complications of orbito-frontobasal fractures]L Cesteleyn, E Akuamo-Boateng, B Kovacs, et al.
Annales De La Societe Belge De Medecine Tropicale|September 1, 1994
Hepatitis C virus antibody, viraemia and genotypes in individuals infected with HIV-1 in CameroonJ N Nkengasong, H Claeys, H De Beenhouwer, et al.
The Journal of Infectious Diseases|May 1, 1995
Predominantly hepatitis C virus genotypes 1 and 2 are found in CameroonJ N Nkengasong, P Nyambi, H Claeys, et al.
The American Journal of Tropical Medicine and Hygiene|January 1, 1995
A pilot study of the prevalence of hepatitis C virus antibodies and hepatitis C virus RNA in southern CameroonJ N Nkengasong, H De Beenhouwer, H Claeys, et al.
European Journal of Immunology|November 1, 1980
Interferon induced in human leukocytes by mitogens: production, partial purification and characterizationM de Ley, J van Damme, H Claeys, et al.
Neurology|October 1, 1986
Transfer factor therapy in multiple sclerosis: a three-year prospective double-blind clinical trialH Van Haver, F Lissoir, C Droissart, et al.
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|February 8, 2007
[Influenza: an example of interdisciplinary analysis of risks]P Vanthemsche, E Robesyn, H Claeys, et al.
Kidney International|March 1, 1996
Hepatitis C virus in a hemodialysis unit: molecular evidence for nosocomial transmissionL Stuyver, H Claeys, A Wyseur, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1981
Interferon therapy in multiple myeloma: failure of human fibroblast interferon administration to the course of light chain diseaseA Billiau, J Bloemmen, M Bogaerts, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of the Neurological Sciences|July 1, 1983
Interferon production and natural killer (NK) activity in leukocyte cultures from multiple sclerosis patientsG Vervliet, H Claeys, H Van Haver, et al.
Acta Stomatologica Belgica|June 1, 1992
[Complications of orbito-frontobasal fractures]L Cesteleyn, E Akuamo-Boateng, B Kovacs, et al.
Annales De La Societe Belge De Medecine Tropicale|September 1, 1994
Hepatitis C virus antibody, viraemia and genotypes in individuals infected with HIV-1 in CameroonJ N Nkengasong, H Claeys, H De Beenhouwer, et al.
The Journal of Infectious Diseases|May 1, 1995
Predominantly hepatitis C virus genotypes 1 and 2 are found in CameroonJ N Nkengasong, P Nyambi, H Claeys, et al.
The American Journal of Tropical Medicine and Hygiene|January 1, 1995
A pilot study of the prevalence of hepatitis C virus antibodies and hepatitis C virus RNA in southern CameroonJ N Nkengasong, H De Beenhouwer, H Claeys, et al.
European Journal of Immunology|November 1, 1980
Interferon induced in human leukocytes by mitogens: production, partial purification and characterizationM de Ley, J van Damme, H Claeys, et al.
Neurology|October 1, 1986
Transfer factor therapy in multiple sclerosis: a three-year prospective double-blind clinical trialH Van Haver, F Lissoir, C Droissart, et al.
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|February 8, 2007
[Influenza: an example of interdisciplinary analysis of risks]P Vanthemsche, E Robesyn, H Claeys, et al.
Kidney International|March 1, 1996
Hepatitis C virus in a hemodialysis unit: molecular evidence for nosocomial transmissionL Stuyver, H Claeys, A Wyseur, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1981
Interferon therapy in multiple myeloma: failure of human fibroblast interferon administration to the course of light chain diseaseA Billiau, J Bloemmen, M Bogaerts, et al.
Pageof 4